Trends in utilization of topical medications for treatment of rosacea in the United States (2005-2014): A cohort analysis

J Am Acad Dermatol. 2019 Apr;80(4):1135-1137. doi: 10.1016/j.jaad.2018.09.039. Epub 2018 Oct 2.

Authors

Hadar Lev-Tov¹, Joanne S Rill², Guodong Liu³, Joslyn S Kirby⁴

Affiliations

¹ Dr Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida. Electronic address: hlevtov@med.miami.edu.
² Dermatology Associates of Lancaster, Lancaster, Pennsylvania.
³ Division of Health Services Research, Department of Public Health Sciences, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
⁴ Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

PMID: 30287319
DOI: 10.1016/j.jaad.2018.09.039

No abstract available

Publication types

Letter

MeSH terms

Administration, Cutaneous
Adult
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / therapeutic use*
Cohort Studies
Dermatologic Agents / administration & dosage
Dermatologic Agents / therapeutic use*
Dicarboxylic Acids / administration & dosage
Dicarboxylic Acids / therapeutic use*
Drug Costs / statistics & numerical data
Drug Therapy, Combination
Drug Utilization / trends*
Drugs, Generic / economics
Female
Humans
Male
Metronidazole / administration & dosage
Metronidazole / therapeutic use*
Middle Aged
Retrospective Studies
Rosacea / drug therapy*
Rosacea / economics*
United States

Substances

Anti-Bacterial Agents
Dermatologic Agents
Dicarboxylic Acids
Drugs, Generic
Metronidazole
azelaic acid